Fig. 1 · Structure
Documents & Downloads
Insulin aspart
Insulin Analog
Insulin aspart (B28Asp) is a fast-acting insulin analog that enhances therapeutic outcomes for diabetes management. Its modified structure facilitates quicker absorption following subcutaneous administration compared to regular human insulin. This makes insulin aspart well-suited for research applications focused on glycemic control and insulin response in diabetic models.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 116094-23-6 |
| Applications | Insulin Analog |
| Formula | C256H381N65O79S6 |
| Synonyms | B28Asp; B28-Asp-insulin; INA-X 14; Insulin X 14 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.